Security Snapshot

Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share (ALHC) Institutional Ownership

CUSIP: 01625V104

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

263

Shares (Excl. Options)

191,724,073

Price

$19.75

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Class A common stock, par value $0.001 per share
Symbol
ALHC on Nasdaq
Shares outstanding
199,511,106
Price per share
$21.66
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
191,724,073
Total reported value
$3,786,365,550
% of total 13F portfolios
0.01%
Share change
+8,032,159
Value change
+$161,603,277
Number of holders
263
Price from insider filings
$21.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ALHC - Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share is tracked under CUSIP 01625V104.
  • 263 institutions reported positions in Q4 2025.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 263 to 51 between Q4 2025 and Q1 2026.
  • Reported value moved from $3,786,365,550 to $74,461,792.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 263 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 01625V104?
CUSIP 01625V104 identifies ALHC - Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share (ALHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 7.7% +15% $305,985,938 +$43,232,931 15,492,802 +16% The Vanguard Group 31 Dec 2025
FMR LLC 7.7% +88% $292,146,569 +$127,975,805 14,792,082 +78% FMR LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 7.3% +28% $299,428,603 +$63,439,212 14,070,893 +27% Wellington Management Group LLP 31 Dec 2025
Qatar Investment Authority 6.7% $199,353,745 13,246,096 Qatar Investment Authority 17 Sep 2025
GENERAL ATLANTIC, L.P. 6.6% -48% $280,209,358 -$236,622,832 13,167,733 -46% GENERAL ATLANTIC, L.P. 31 Dec 2025
T. Rowe Price Investment Management, Inc. 6.2% $171,410,908 12,331,720 T. Rowe Price Investment Management, Inc. 30 Jun 2025
BlackRock, Inc. 5.4% $187,769,346 10,760,421 BlackRock, Inc. 30 Sep 2025
Flynn James E 3.8% $129,213,102 7,304,302 Deerfield Mgmt, L.P. 31 Dec 2024
CITADEL ADVISORS LLC 3.4% -38% $117,229,222 -$66,136,407 6,718,007 -36% Kenneth Griffin 30 Sep 2025

As of 31 Dec 2025, 263 institutional investors reported holding 191,724,073 shares of Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share (ALHC). This represents 96% of the company’s total 199,511,106 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share (ALHC) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 7.8% 15,492,802 +11% 0% $305,982,839
FMR LLC 7.3% 14,655,935 +81% 0.01% $289,454,723
WELLINGTON MANAGEMENT GROUP LLP 7.1% 14,070,893 +27% 0.05% $277,900,137
BlackRock, Inc. 6.9% 13,711,314 +1% 0% $270,798,462
GENERAL ATLANTIC, L.P. 6.6% 13,167,733 -46% 9.1% $260,062,727
T. Rowe Price Investment Management, Inc. 6.3% 12,643,784 +0.63% 0.16% $249,715,000
Invesco Ltd. 3.1% 6,202,592 +39% 0.02% $122,501,192
Hood River Capital Management LLC 3.1% 6,173,433 +4.3% 1.3% $121,925,302
PRICE T ROWE ASSOCIATES INC /MD/ 2.7% 5,466,117 -1.9% 0.01% $107,956,000
CITADEL ADVISORS LLC 2.2% 4,340,866 -30% 0.06% $85,732,103
GEODE CAPITAL MANAGEMENT, LLC 1.9% 3,841,703 +8.4% 0% $75,884,258
VOYA INVESTMENT MANAGEMENT LLC 1.8% 3,672,439 +15% 0.07% $72,530,671
STATE STREET CORP 1.8% 3,668,602 +14% 0% $72,454,890
RENAISSANCE TECHNOLOGIES LLC 1.3% 2,667,200 -10% 0.08% $52,677,200
MILLENNIUM MANAGEMENT LLC 1.3% 2,567,066 -53% 0.04% $50,699,554
Broad Bay Capital Management, LP 1.3% 2,510,760 +5.7% 5.7% $49,587,510
MORGAN STANLEY 1.2% 2,362,546 +19% 0% $46,660,284
NEXT CENTURY GROWTH INVESTORS LLC 1.2% 2,308,287 +1.6% 3.2% $45,588,668
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.2% 2,305,255 +8.7% 0.13% $45,528,786
Capital World Investors 1.1% 2,238,147 0.01% $44,203,403
LOOMIS SAYLES & CO L P 1.1% 2,236,058 0.05% $44,162,146
Integral Health Asset Management, LLC 1.1% 2,200,000 +38% 2.2% $43,450,000
Nuveen, LLC 1.1% 2,137,007 -1.6% 0.01% $42,205,888
Point72 Asset Management, L.P. 1% 2,041,856 -28% 0.06% $40,326,656
Danica Pension, Livsforsikringsaktieselskab 1% 2,000,000 0.57% $39,500,000

Institutional Holders of Alignment Healthcare, Inc. - Class A common stock, par value $0.001 per share (ALHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,223,035 $74,461,792 -$38,085,870 $17.62 51
2025 Q4 191,724,073 $3,786,365,550 +$161,603,277 $19.75 263
2025 Q3 183,818,109 $3,207,027,055 -$79,949,521 $17.45 232
2025 Q2 188,603,774 $2,640,543,499 +$73,501,748 $14.00 213
2025 Q1 181,046,931 $3,370,573,445 +$108,325,712 $18.62 202
2024 Q4 175,941,934 $1,979,575,066 +$92,170,473 $11.25 169
2024 Q3 166,516,410 $1,968,139,568 -$11,991,531 $11.82 135
2024 Q2 168,001,667 $1,313,040,967 +$35,275,143 $7.82 114
2024 Q1 163,953,772 $813,215,197 -$12,956,614 $4.96 126
2023 Q4 162,823,740 $1,401,627,972 +$10,408,708 $8.61 118
2023 Q3 161,868,889 $1,123,233,042 +$1,667,897 $6.94 128
2023 Q2 161,974,767 $931,514,288 +$4,787,796 $5.75 138
2023 Q1 160,141,678 $1,019,066,032 -$29,743,128 $6.36 128
2022 Q4 162,219,260 $1,907,291,906 +$61,190,841 $11.76 142
2022 Q3 157,118,193 $1,861,199,199 -$75,922,936 $11.84 147
2022 Q2 155,949,051 $1,782,084,839 +$15,490,235 $11.41 89
2022 Q1 154,534,705 $1,734,668,822 -$11,447,578 $11.23 88
2021 Q4 153,488,401 $2,157,686,975 +$61,469,066 $14.06 94
2021 Q3 149,167,029 $2,384,004,236 +$14,294,551 $15.98 63
2021 Q2 148,224,293 $3,445,150,706 +$63,208,372 $23.37 55
2021 Q1 145,696,477 $3,166,763,000 +$3,166,763,000 $21.93 51
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .